| ADI-905-312-100 | 100 µg | 458.00 USD |  |
||
| Do you need bulk/larger quantities? | |||||
| Alternative Name: | TNFRSF 13B, Transmembrane activator and CAML interactor, CD267 |
| Host: | Rabbit |
| Immunogen: | Synthetic peptide corresponding to the sequence near the N-terminus of human TACI. |
| UniProt ID: | O14836 |
| Species reactivity: | Human |
| Applications: | ICC, WB |
| Recommended Dilutions/Conditions: | Immunocytochemistry (2µg/ml) Western Blot (2-5µg/ml) Suggested dilutions/conditions may not be available for all applications. Optimal conditions must be determined individually for each application. |
| Application Notes: | Detects a band of ~30kDa by Western blot. |
| Purity Detail: | Peptide affinity purified. |
| Formulation: | Liquid. In PBS containing 0.02% sodium azide. |
| Shipping: | Blue Ice Not Frozen |
| Long Term Storage: | +4°C |
| Scientific Background: | TACI (transmembrane activator and CAML interactor), also known as TNF receptor superfamily member 13B, is a lymphocyte-specific member of the TNF-R family. TACI and its ligands (BAFF, APRIL) regulate humoral immune responses, activate NF-κB and c-jun N-terminal kinase, and play a role in B cell associated autoimmune diseases. Mutations in TACI are associated with a subset of common variable immunodeficiency (CVID). |
| Regulatory Status: | RUO - Research Use Only |
Goat anti-rabbit IgG, polyclonal antibody (HRP conjugate) |
||||||
| ELISA, IHC, WB | Print as PDF | ||||||
| ADI-SAB-300-J | 1 ml | 154.00 USD | |
|||
| Do you need bulk/larger quantities? | ||||||
